Episode Details

Back to Episodes
Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration

Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration

Published 3 months, 3 weeks ago
Description
In today's Pharmaceutical Executive Daily, BioMarin and n-Lorem Foundation partner on the first disease-targeted therapy for the recently identified ReNU syndrome, a trio of biotech financings advance rare disease, sleep apnea, and oncology pipelines, and a Wharton professor offers career advice for MBA graduates navigating an AI-reshaped job market.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us